Here, after metformin failure, GLP-1 receptor agonists, or SGLT-2 inhibitors are recommended as second line therapy or as third line therapy in combination
In trials, people using Mounjaro experienced a weight loss of 26.6% over 84 weeks, which stands out when juxtaposed with results from those taking Ozempic, a different medication for weight reduction
These can help regulate appetite, improve fat metabolism, and maintain steady blood sugar levels
Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism
They can cause respiratory depression, dizziness, drowsiness, and impaired coordination
Many patients who initially struggle with side effects achieve tolerance by month three with proper support and management strategies